This is a phenomenal high-quality resource that guides surgeons & surgeon-trainees in academic work. It fills a real gap in the best way!

An excellent resource for surgeons of all grader – invaluable.

The rise of Annals of Breast Surgery's impact factor from 0.9 to 1.8 reflects the growing relevance and quality of the work published in the journal. Breast surgery is evolving rapidly, increasingly integrated with systemic therapy, genomics, and multidisciplinary care, and ABS has positioned itself as a valuable forum for this dialogue. I congratulate the editorial team, reviewers, and authors, and I encourage the journal to continue prioritizing methodological rigor and studies relevant to diverse healthcare settings, including low- and middle-resource countries. I look forward to seeing ABS reach even greater visibility in the coming years.

I had the honor and pleasure of being welcomed to the editorial board of Translational Breast Cancer Research in 2023, when the journal was still in its infancy. I believed in their professionalism and rigor from the beginning, convinced that, over time, TBCR would receive the recognition it deserved. And so it did. The accolades were not long in coming, and now TBCR is a scientific benchmark in breast cancer research.

Ad majora!

Congratulations on the marvelous achievement of Translational Breast Cancer Research (TBCR)! I wish TBCR continued progress at the forefront of scientific publishing.     

Congratulations to TBCR on this outstanding achievement. It has been a pleasure to serve on the Editorial Board and witness the journal's remarkable progress. The dedication and professionalism of the editorial team, reviewers, and authors have established TBCR as an important forum for impactful translational breast cancer research. I am excited about the journal's bright future and look forward to supporting its continued growth, scientific excellence, and global impact in improving the lives of patients with breast cancer.